Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q92059050 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000247.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q92059050 | ||
| 024 | ‡a 0000-0001-7957-2463 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q92059050 | ||
| 100 | 0 | ‡a Bert Andersson ‡c researcher (ORCID 0000-0001-7957-2463) ‡9 en | |
| 400 | 0 | ‡a Bert Andersson ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials | ||
| 670 | ‡a Author's Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment:A Randomized Double-Blind Controlled Trial | ||
| 670 | ‡a Author's Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis | ||
| 670 | ‡a Author's Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis | ||
| 670 | ‡a Author's Factors influencing long-term heart failure mortality in patients with obstructive hypertrophic cardiomyopathy in Western Sweden: probable dose-related protection from beta-blocker therapy | ||
| 670 | ‡a Author's Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure | ||
| 670 | ‡a Author's Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis | ||
| 670 | ‡a Author's Parvovirus B19 in Endomyocardial Biopsy of Patients With Idiopathic Dilated Cardiomyopathy: Foe or Bystander? | ||
| 909 | ‡a (orcid) 0000000179572463 ‡9 1 | ||
| 919 | ‡a betablockersforheartfailurewithreducedmidrangeandpreservedejectionfractionanindividualpatientlevelanalysisofdoubleblindrandomizedtrials ‡A Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials ‡9 1 | ||
| 919 | ‡a differentialeffectsoflevosimendananddobutamineonglomerularfiltrationrateinpatientswithheartfailureandrenalimpairmentarandomizeddoubleblindcontrolledtrial ‡A Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment:A Randomized Double-Blind Controlled Trial ‡9 1 | ||
| 919 | ‡a effectofageandsexonefficacyandtolerabilityofβblockersinpatientswithheartfailurewithreducedejectionfractionindividualpatientdatametaanalysis ‡A Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis ‡9 1 | ||
| 919 | ‡a efficacyofβblockersinpatientswithheartfailureplusatrialfibrillationanindividualpatientdatametaanalysis ‡A Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis ‡9 1 | ||
| 919 | ‡a factorsinfluencinglongtermheartfailuremortalityinpatientswithobstructivehypertrophiccardiomyopathyinwesternswedenprobabledoserelatedprotectionfrombetablockertherapy ‡A Factors influencing long-term heart failure mortality in patients with obstructive hypertrophic cardiomyopathy in Western Sweden: probable dose-related protection from beta-blocker therapy ‡9 1 | ||
| 919 | ‡a impactofrenalimpairmentonbetablockerefficacyinpatientswithheartfailure ‡A Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure ‡9 1 | ||
| 919 | ‡a isheartrateariskmarkerinpatientswithchronicheartfailureandconcomitantatrialfibrillationresultsfromthemaggicmetaanalysis ‡A Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis ‡9 1 | ||
| 919 | ‡a parvovirusb19inendomyocardialbiopsyofpatientswithidiopathicdilatedcardiomyopathyfoeorbystander ‡A Parvovirus B19 in Endomyocardial Biopsy of Patients With Idiopathic Dilated Cardiomyopathy: Foe or Bystander? ‡9 1 | ||
| 996 | ‡2 SELIBR|210162 | ||
| 996 | ‡2 SUDOC|17589177X | ||
| 996 | ‡2 LC|n 89626958 | ||
| 996 | ‡2 SELIBR|280150 | ||
| 996 | ‡2 DNB|142147915 | ||
| 996 | ‡2 SELIBR|332621 | ||
| 996 | ‡2 BIBSYS|9022564 | ||
| 996 | ‡2 CAOONL|ncf11707035 | ||
| 996 | ‡2 BIBSYS|3107952 | ||
| 996 | ‡2 ISNI|0000000053791222 | ||
| 996 | ‡2 DNB|115409785 | ||
| 996 | ‡2 ISNI|0000000384004107 | ||
| 996 | ‡2 NTA|067726062 | ||
| 996 | ‡2 SUDOC|111361672 | ||
| 996 | ‡2 BIBSYS|3059676 | ||
| 996 | ‡2 LC|no2006099494 | ||
| 996 | ‡2 LC|n 95081953 | ||
| 996 | ‡2 BIBSYS|90312264 | ||
| 996 | ‡2 NTA|071848258 | ||
| 996 | ‡2 BIBSYS|2110602 | ||
| 996 | ‡2 BNF|15601054 | ||
| 996 | ‡2 SELIBR|303837 | ||
| 996 | ‡2 ISNI|0000000077164231 | ||
| 996 | ‡2 BIBSYS|90308267 | ||
| 996 | ‡2 LC|nb2012030067 | ||
| 996 | ‡2 DBC|87097990067788 | ||
| 996 | ‡2 BIBSYS|90778573 | ||
| 996 | ‡2 BIBSYS|90299838 | ||
| 996 | ‡2 NUKAT|n 2008104712 | ||
| 996 | ‡2 NTA|147381444 | ||
| 996 | ‡2 BIBSYS|2093834 | ||
| 996 | ‡2 ISNI|0000000391608734 | ||
| 996 | ‡2 BIBSYS|1054038 | ||
| 996 | ‡2 SELIBR|277659 | ||
| 996 | ‡2 BIBSYS|90970947 | ||
| 996 | ‡2 DBC|87097968066948 | ||
| 996 | ‡2 SELIBR|223174 | ||
| 996 | ‡2 ISNI|0000000382983364 | ||
| 996 | ‡2 LC|n 85217332 | ||
| 996 | ‡2 BIBSYS|5026190 | ||
| 996 | ‡2 DNB|142147877 | ||
| 996 | ‡2 DBC|87097946611209 | ||
| 996 | ‡2 BIBSYS|6068171 | ||
| 996 | ‡2 ISNI|0000000045911626 | ||
| 996 | ‡2 ISNI|0000000030449432 | ||
| 996 | ‡2 DNB|1287293263 | ||
| 996 | ‡2 NTA|073649937 | ||
| 996 | ‡2 W2Z|1054038 | ||
| 996 | ‡2 NTA|304084492 | ||
| 996 | ‡2 BIBSYS|90642246 | ||
| 996 | ‡2 BIBSYS|90649133 | ||
| 996 | ‡2 SELIBR|213733 | ||
| 996 | ‡2 ISNI|0000000051511960 | ||
| 996 | ‡2 ISNI|0000000031950747 | ||
| 996 | ‡2 LC|n 88195596 | ||
| 996 | ‡2 BIBSYS|10005160 | ||
| 996 | ‡2 BIBSYS|90720581 | ||
| 996 | ‡2 LC|nb2009002704 | ||
| 996 | ‡2 LC|n 2007030949 | ||
| 996 | ‡2 DNB|115371354 | ||
| 996 | ‡2 SUDOC|114968748 | ||
| 996 | ‡2 DNB|1157736696 | ||
| 996 | ‡2 SELIBR|411000 | ||
| 996 | ‡2 ISNI|0000000054860824 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
